Editor’s note: This is the fifth in a six-post series on how Fuentek views technology licensing through a new PRISM. Many people cite Winston Churchill as saying that “Consistency is the hobgoblin of little minds.” But there is a key word they’re leaving out of that...
Editor’s note: This is the third in a six-post series on how Fuentek views technology licensing through a new PRISM. How do you decide if the return is worth the investment when you’re prioritizing your technology licensing opportunities? There are lots of methods for...
Editor’s note: This is the second in a six-post series on how Fuentek views technology licensing through a new PRISM. Whether your intellectual property (IP) portfolio is small or enormous, prioritizing your commercialization opportunities let’s you put your money and...
Doesn’t an acronym make everything better? Seriously, sometimes the act of sitting down and thinking through the essence of what you do in an effort to come up with a clever, memorable acronym leads you to greater clarity about what’s really important. PRISM is...
Again and again we hear about how innovations developed at NASA for the space program are being used outside the agency for entirely new applications—thanks to the technology commercialization successes of NASA’s technology transfer program, the Innovative...
Get useful tech transfer tips and news delivered right to your inbox!
By submitting this form, you are consenting to receive emails from: Fuentek, LLC. You can unsubscribe at any time by clicking the link at the bottom of every email.
